Basics Cerus Corporation Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety. IPO Date: January 31, 1997 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $397.62M Activated in VL: True Average Daily Range Avg Daily Range: $0.11 | 2.75% Avg Daily Range (30 D): $0.06 | 3.45% Avg Daily Range (90 D): $0.05 | 3.26% Institutional Daily Volume Avg Daily Volume: .75M Avg Daily Volume (30 D): 1.12M Avg Daily Volume (90 D): 1.16M Trade Size Avg Trade Size (Sh.): 178 Avg Trade Size (Sh.) (30 D): 189 Avg Trade Size (Sh.) (90 D): 198 Institutional Trades Total Inst.Trades: 956 Avg Inst. Trade: $1.27M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $.77M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.26M Avg Closing Trade (30 D): $.5M Avg Closing Trade (90 D): $.75M Avg Closing Volume: 228.03K     News Jul 17, 2024 @ 12:21 PM ASML Reports Q2 Results, Joins Spirit Airlines And... Source: Avi Kapoor Jul 17, 2024 @ 10:03 AM Why Bloom Energy Group Shares Are Trading Higher B... Source: Avi Kapoor Apr 8, 2024 @ 12:24 PM Perion Network Cuts Sales Outlook, Joins Range Res... Source: Avi Kapoor Mar 21, 2024 @ 3:40 AM Cathie Wood's Ark Invest Sells Another Tranche Of ... Source: Benzinga Neuro Mar 14, 2024 @ 3:41 AM Cathie Wood's Ark Invest Sells Coinbase Shares As ... Source: Benzinga Neuro Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.08 $ $-.03 Diluted EPS $-.08 $ $-.03 Revenue $ 217.45M $ 35.68M $ 36.66M Gross Profit $ $ $ Net Income / Loss $ -16.02M $ -.02M $ -5.72M Operating Income / Loss $ -9.49M $ 1.24M $ -3.42M Cost of Revenue $ $ $ Net Cash Flow $ -6.4M $ -.32M $ -3.45M PE Ratio